Senti Bio Announces Publication Of SENTI-202 Preclinical Data Demonstrating Potential Of Logic-Gated CAR-NK Cell Therapy For The Treatment Of Acute Myeloid Leukemia
Senti Bio Announces Publication Of SENTI-202 Preclinical Data Demonstrating Potential Of Logic-Gated CAR-NK Cell Therapy For The Treatment Of Acute Myeloid Leukemia
Senti Bio 宣佈發佈 SENTI-202 臨床前數據，顯示邏輯門控 CAR-NK 細胞療法治療急性髓系白血病的潛力
Senti Bio Announces Publication Of SENTI-202 Preclinical Data Demonstrating Potential Of Logic-Gated CAR-NK Cell Therapy For The Treatment Of Acute Myeloid Leukemia
Senti Bio 宣佈發佈 SENTI-202 臨床前數據，顯示邏輯門控 CAR-NK 細胞療法治療急性髓系白血病的潛力
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。